Dimensional Fund Advisors’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-95,083
Closed -$66.2K 3539
2023
Q1
$66.2K Sell
95,083
-106,981
-53% -$86.7K ﹤0.01% 3360
2022
Q4
$166 Hold
202,064
﹤0.01% 3257
2022
Q3
$210K Sell
202,064
-428,414
-68% -$685K ﹤0.01% 3228
2022
Q2
$1.03M Sell
630,478
-112,484
-15% -$234K ﹤0.01% 2909
2022
Q1
$2.18M Buy
742,962
+337,985
+83% +$1.18M ﹤0.01% 2803
2021
Q4
$1.94M Buy
404,977
+139,310
+52% +$899K ﹤0.01% 2854
2021
Q3
$2.01M Sell
265,667
-360,849
-58% -$2.31M ﹤0.01% 2855
2021
Q2
$4.67M Buy
626,516
+125,002
+25% +$963K ﹤0.01% 2633
2021
Q1
$3.91M Buy
501,514
+332,410
+197% +$3.32M ﹤0.01% 2658
2020
Q4
$1.56M Buy
169,104
+85,190
+102% +$740K ﹤0.01% 2872
2020
Q3
$578K Buy
83,914
+59,370
+242% +$360K ﹤0.01% 3031
2020
Q2
$161K Hold
24,544
﹤0.01% 3233
2020
Q1
$46K Buy
+24,544
New +$64.7K ﹤0.01% 3326
2019
Q3
Sell
-14,739
Closed -$42K 3443
2019
Q2
$42K Sell
14,739
-7,317
-33% -$29.1K ﹤0.01% 3433
2019
Q1
$105K Buy
+22,056
New +$109K ﹤0.01% 3375

Other funds holding SURF

Dimensional Fund Advisors's SURF Position: Q2 2023 in Review

Dimensional Fund Advisors sold out of Surface Oncology, Inc. Common Stock (SURF) in Q2 2023, closing a stake of 95,083 shares — an estimated $66.2K sold.

Dimensional Fund Advisors first reported a position in SURF in Q1 2019 and held it in 15 quarters. The position peaked at $4.67M in Q2 2021. 61 funds tracked by Wall St. Rank hold SURF as of Q2 2023.

  • Dimensional Fund Advisors reported no remaining Surface Oncology, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Dimensional Fund Advisors sold 95,083 Surface Oncology, Inc. Common Stock shares in Q2 2023, an estimated $66.2K.
  • Dimensional Fund Advisors first reported a position in Surface Oncology, Inc. Common Stock in Q1 2019 and held it in 15 quarters.
  • Dimensional Fund Advisors's Surface Oncology, Inc. Common Stock position peaked at $4.67M in Q2 2021.
  • 61 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q2 2023.

Based on Dimensional Fund Advisors's 13F filing for Q2 2023, filed 9 Aug 2023.